IBM Workload Scheduler Distributed 9.2/9.3/9.4/9.5 privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.2 | $5k-$25k | 0.00 |
Summary
A vulnerability was found in IBM Workload Scheduler Distributed 9.2/9.3/9.4/9.5. It has been rated as critical. This issue affects some unknown processing. This manipulation causes privileges management. This vulnerability is handled as CVE-2019-4031. It is possible to launch the attack on the local host. There is not any exploit available.
Details
A vulnerability was found in IBM Workload Scheduler Distributed 9.2/9.3/9.4/9.5. It has been declared as critical. Affected by this vulnerability is an unknown function. The manipulation with an unknown input leads to a privileges management vulnerability. The CWE definition for the vulnerability is CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:
IBM Workload Scheduler Distributed 9.2, 9.3, 9.4, and 9.5 contains a vulnerability that could allow a local user to write files as root in the file system, which could allow the attacker to gain root privileges. IBM X-Force ID: 155997.
The weakness was released 10/16/2019 (Website). The advisory is shared at exchange.xforce.ibmcloud.com. This vulnerability is known as CVE-2019-4031 since 01/03/2019. An attack has to be approached locally. The successful exploitation requires a single authentication. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 01/09/2024). It is expected to see the exploit prices for this product increasing in the near future.MITRE ATT&CK project uses the attack technique T1068 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.2VulDB Meta Temp Score: 8.2
VulDB Base Score: 7.8
VulDB Temp Score: 7.8
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 8.4
NVD Vector: 🔍
CNA Base Score: 8.4
CNA Vector (IBM Corporation): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: Partially
Local: Yes
Remote: No
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
01/03/2019 🔍10/16/2019 🔍
10/16/2019 🔍
01/09/2024 🔍
Sources
Vendor: ibm.comAdvisory: exchange.xforce.ibmcloud.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2019-4031 (🔍)
GCVE (CVE): GCVE-0-2019-4031
GCVE (VulDB): GCVE-100-143521
X-Force: 155997
Entry
Created: 10/16/2019 18:13Updated: 01/09/2024 08:25
Changes: 10/16/2019 18:13 (38), 10/16/2019 18:18 (17), 01/09/2024 08:23 (3), 01/09/2024 08:25 (12)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.